Greater China
HighLight hits $300m first close on China healthcare fund
Chinese healthcare-focused GP HighLight Capital has reached the first close of $300 million on its third US dollar-denominated fund, but further progress is likely to be delayed by the coronavirus outbreak.
Hong Kong crypto finance start-up raises $28m
Amber Group, a Hong Kong-based start-up offering crypto-based financial services, has raised $28 million in a Series A round led by Paradigm and Pantera Capital.
China space tech: Aligning the stars
SpaceX-inspired global fervor about the possibilities of space technology has infiltrated China. Some start-ups appear well set for commercial lift-off, but many others will misfire
CICC raises $229m for China healthcare fund
China's CICC Capital has raised RMB1.6 billion ($229 million) for its first fund dedicated to the biopharmaceutical space.
Chinese fashion design platform raises $14m
Linctex Digital, a Shanghai-based design services platform for the fashion industry, has raised RMB100 million ($14 million) in funding led by Gaorong Capital. Shunwei Capital, Vision Plus Capital, Baidu Ventures and Yinxinggu Capital also took part.
Carlyle Asia secures exit as Permira buys Golden Goose for $1.4b
Golden Goose, an Italian luxury footwear brand acquired three years ago by The Carlyle Group’s Europe and Asia funds, has been sold to Permira for around EUR1.3 billion ($1.4 billion).
Chinese online insurance player raises $55m in US IPO
Huize Holding, a Shanghai-based insurance platform backed by SAIF Partners, has raised about $55 million in a US IPO.
Hamilton Lane backs Legend Capital fund restructuring
Hamilton Lane has led a $200 million restructuring of a VC fund managed by China-based Legend Capital, transferring 12 investments into a new vehicle as a means of extending the holding period.
China B2B platform Yijiupi raises new round, buys Zskuaixiao
Yijiupi, a Chinese B2B e-commerce platform that initially focused on liquor products, has acquired local B2B consumer goods distributor Zskuaixiao. It has also secured a new round of funding backed by several Zskuaixiao investors.
1955 Capital wins case against Chinese anchor LP
Cross-border technology investor 1955 Capital has emerged victorious in a legal battle with its Chinese anchor LP after a US court upheld an earlier arbitration ruling that the LP had no grounds for withdrawing from the fund.
Chinese medical imaging business secures $86m Series B
Shanghai-based Universal Medical Imaging, China’s largest independent imaging diagnosis company has raised a RMB600 million ($86 million) Series B round led by Cathay Capital, V Star Capital and CEC Capital.
Deal focus: Lightspeed targets solid-state LiDAR
Having assessed some 40 autonomous driving companies globally, Lightspeed China Partners decided that Hesai - a business born in the US and raised in China - is best-placed to take the technology forwards
LP interview: Manulife Investment Management
Manulife Investment Management is easing into its first Asian private markets drive with a focus on optionality. Private credit, infrastructure, and real estate are early areas of interest
PE-backed Akeso Biopharma targets Hong Kong IPO
Chinese biotech player Akeso Biopharma has made a second attempt at filing for a Hong Kong IPO after its previous application was rejected last month for failing to meet regulatory requirements.
Portfolio level HR: Human traffic
Private equity firms in Asia are paying more attention to recruitment at the portfolio level, in some cases allocating dedicated in-house resources. How is it impacting attitudes towards leadership change?
AVCJ Awards 2019: Deal of the Year - Small Cap: AffaMed Therapeutics
CBC Group established biosimilars specialist AffaMed Therapeutics to remove uncertainties in the development process and to tap Chinese demand for affordable treatments
Joy Capital leads $88m round for China's Shihuituan
Joy Capital has announced its participation - as the lead investor - in an $88.3m funding round for Chinese community group buying platform Shihuituan, which is also known as Nice Tuan.
Chinese genetic testing player for infectious diseases gets Series B+
Chinese genetic testing specialist Genskey raised an RMB50 million ($7.1m) extended Series B round of funding led by Shenzhen-based Fortune Capital. Existing investor Legend Capital re-upped.
Japan's TDK invests air mobility developer
Japan’s TDK Corporation has made a VC commitment of undisclosed size in AutoFlightX, an electric air mobility company based in Germany with a significant China presence.
Raffles Family Office backs Hong Kong co-working space player
Hong Kong-based multi-family office Raffles Family Office will invest $15 million in local co-working space operator WorkTech.
AVCJ Awards 2019: Firm of the Year - Mid Cap: Centurium Capital
China-focused Centurium Capital has enjoyed a productive 12 months, closing its debut US dollar fund, deploying most of the capital, and securing an early liquidity event
China-US tensions: Adapting to malaise
China would suffer the most immediate impact of a technology decoupling with the US, but both sides would be damaged in the long-term in the absence of remedial action
CITIC Capital targets OBOR deals with blank check company
CITIC Capital has launched a special purpose acquisition vehicle (SPAC) – or blank check company – on the New York Stock Exchange to pursue deals under its One Belt One Road (OBOR) strategy.
Centurium leads $100m Series D for China's Yunxuetang
Yunxuetang, an online corporate training services provider focused on China, has raised $100 million in Series D funding led by Centurium Capital. Existing investors Yunfeng Capital and SIG both re-upped.
